December 7, 2026-December 8, 2026 NIH/NCATS, C-Path Joint Meeting Please join us at the 28th NIH Tissue Chip Consortium Joint Meeting with the CC-Path's Complex In Vitro Model Qualification...
November 18, 2026 Collaboration as the Solution to the ‘Predictability Paradox’ in Drug Development TUCSON, Ariz., November 18, 2026 — Biomedical science can increasingly design therapies targeting specific genetic...
November 18, 2026 The Critical Path Institute Podcast: Advancing Alpha-1 Antitrypsin Deficiency Treatment Through Collaboration and Patient-Centered Innovation This episode of the Critical Path Institute Podcast features an in-depth conversation between podcast host and C-Path CEO...
November 10, 2026 C-Path and AFTD Partner to Bring Frontotemporal Degeneration Data into Rare Disease Data Platform for the First Time C-Path and the Association for Frontotemporal Degeneration (AFTD) today announced a new data-sharing...
November 6, 2026 An integrative roadmap for a new era of kidney replacement therapies Innovation in kidney replacement is entering a transformative era. Although precision medicine has driven major...
November 3, 2026 White House Signs off on ACT for ALS Reauthorization President Trump's signature provides final step to extending programs established by the original ACT for ALS through 2031.
October 30, 2026 Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation Tau positron emission tomography (PET) tracers differ in kinetics, binding properties...
October 29, 2026 Overcoming the challenges of rare disease clinical research Development of drugs to treat rare diseases faces unique challenges. Traditional placebo-controlled clinical trials may be difficu
October 9, 2026 Critical Path Institute Newsletter Q3 2026: Patient-Focused. Future-Ready. Evidence-Driven As we enter the final quarter of 2026, I continue to be inspired by the progress our community is making together. The past severa
October 2, 2026 C-Path Partners with University of Arizona on Translational Research of Parkinson’s Disease in Women TUCSON, Ariz., October 6, 2026 — Critical Path Institute® (C-Path) today announced a research collaboration with the University